24/7 Space News
Creating new and better drugs with protein crystal growth experiments on the ISS
JAXA astronaut Koichi Wakata at work on the ISS.
Creating new and better drugs with protein crystal growth experiments on the ISS
by Staff Writers
Houston TX (SPX) Apr 27, 2023

For more than two decades, the International Space Station has provided a platform for growing and studying protein crystals. In the early days of microgravity research, scientists discovered that they protein crystals grown in space were more uniform and larger than those grown in Earth's gravity. Since then, drug companies and academic researchers have conducted hundreds of protein crystal growth (PCG) experiments on the space station - by far the largest single category of experiments conducted on the orbiting lab.

Proteins are involved in every aspect of our lives, including as essential components of our immune system and as parts of viruses that can make us sick. When we take a medication, it binds to a specific protein in the body. This process changes the protein's function - and if it works properly, that can make us well.

In many diseases, the proteins that can trigger the disease state fit into very specific locations, like a biological keyhole. The protein of a potential drug for treating that disease must be designed to fit that keyhole. A good key and keyhole fit results in a more effective medicine with fewer side effects, but to achieve that fit, scientists need detailed knowledge of the structure of both proteins. One of the best ways to analyze a protein structure is to grow it in crystalline form.

Since 2005, the Kristallizator program from the State Space Corporation Roscosmos has created single protein crystals especially suited for analysis using X-ray diffraction. One outcome of these studies was identifying the structure of a target for anti-tuberculosis drugs, which could help scientists develop a treatment.

JAXA (Japan Aerospace Exploration Agency) has been active in protein crystal growth research in microgravity, accounting for about two-thirds of all PCG experiments on the station. A series of studies, JAXA PCG, has provided precise structures of many protein types and has led to the discovery of potential drugs.

One of these studies examined the crystal structure of a protein associated with Duchenne Muscular Dystrophy (DMD), a currently incurable genetic disorder. The work provided hints for compounds that could inhibit the disease, leading to several promising compounds, including one called TAS-205. The research team estimates the drug may slow the progression of DMD by half, increasing the lifespan of many patients. A clinical trial in human patients was completed in 2017. Co-investigator Mitsugu Yamada of JAXA says a larger Phase 3 trial to examine the effectiveness of TAS-205 in situations similar to actual clinical use began in December 2020 and will continue until 2027.

JAXA Moderate Temperature PCG continued this work, producing high quality crystals to advance basic biochemical knowledge and support drug discovery.

In addition to creating completely new treatments, PCG research on station can lead to drug formulations that are easier to store and last longer - such as those stable at room temperature that eliminate the need for refrigeration. This modification lowers the cost and simplifies distribution of drugs.

PCG-5, work sponsored by the ISS National Lab, focused on how drugs known as monoclonal antibodies are given to patients. Monoclonal antibodies do not dissolve easily in liquid and typically are delivered intravenously, requiring a patient to spend hours in a clinic setting. High-quality crystalline suspensions produced by PCG-5 could enable delivery by injection, making treatment more convenient for patients and caregivers and significantly reducing cost.

Merck Research Laboratories, developer of a series of PCG experiments, produced simple hardware and processes that scientists from other disciplines can use to conduct microgravity research. JAXA has worked to increase interest in PCG research in microgravity as well, developing a technology for membrane protein crystallization, for example. Other studies have advanced the field of protein crystallization by producing new processes for growing high-quality crystals aboard the space station.

By providing a platform for PCG research, the space station plays a key role in bringing people on Earth new and better treatments for diseases.

Related Links
ISS National Lab
Space Tourism, Space Transport and Space Exploration News

Subscribe Free To Our Daily Newsletters

The following news reports may link to other Space Media Network websites.
Russian cosmonauts delay ISS spacewalk
Washington DC (UPI) Apr 25, 2023
Russian cosmonauts have delayed a spacewalk to move one of the airlock systems aboard the International Space Station from one module to another. The delay was announced by Russia's state space exploration company Roscosmos Monday. In a statement on Telegram, Roscosmos said the extravehicular activity "was postponed, tentatively, to the beginning of May due to the need for a more detailed study of its tasks." Cosmonauts Dmitry Petelin and Sergey Prokopyev were originally scheduled ... read more

NASA selects Emily Nelson as Chief Flight Director

Join the webinar on Accessibility in Human Spaceflight

Voyager will do more science with new power strategy

Creating new and better drugs with protein crystal growth experiments on the ISS

SpaceX aborts Starlink launch at last second, delays Falcon Heavy mission

Conservation groups sue US regulator over SpaceX launches

A second pair of SES' O3b mPower satellites launched on a SpaceX rocket

Falcon Heavy launches massive GEO satellite for Viasat

Examining a Potential Drill Spot: Sols 3817-3818

Just a Little Scoot: Sols 3814-3816

Sols 3812-3813: Tiny Sticks Poking Out at Us

Alberta researcher to help select samples to bring back from Mars

Final frontier is no longer alien

China to promote space science progress on five themes

China to develop satellite constellation for deep space exploration

China's space missions break new ground

Viper and T-Rex on double rocket launch

ESA recruiting for key divisional directors

CGI to extend machine learning to LEO satellite network optimisation

Latest two O3b mPOWER satellites successfully launched for SES

Astra announces spacecraft engine contract with Apex

Deep-learning system explores materials' interiors from the outside

Innovative NASA alloy used for 3D printed rocket

Heed the reed: thatcher scientist on mission to revive craft

A stormy, active sun may have kickstarted life on Earth

Webb finds water vapor, but from a rocky planet or its star

Scientists discover rare element in exoplanet's atmosphere

Can ET detect us

Juice's first taste of science from space

New video series captures team working on NASA's Europa Clipper

Work continues to deploy Juice RIME antenna

Icy Moonquakes: Surface Shaking Could Trigger Landslides

Subscribe Free To Our Daily Newsletters

The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.